Its regenerative properties help maintain the integrity of connective tissues, potentially lowering the risk of re-injury and promoting long-term musculoskeletal wellness
Hajek M, Meier-Ewert K, Wirz-Justice A, et al
The tirzepatide DVT case report involved a patient with prior breast cancer
Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect
Martin Hiele followed cyclosporine levels and adjusted drug doses of patients in the trial and provided statistical advice
